These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35078243)

  • 1. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
    El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
    J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.
    van Duin M; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Siersema PD; van Dekken H
    Cytogenet Genome Res; 2007; 118(2-4):130-7. PubMed ID: 18000363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.
    van Dekken H; Tilanus HW; Hop WC; Dinjens WN; Wink JC; Vissers KJ; van Marion R
    Cancer Genet Cytogenet; 2009 Feb; 189(1):37-42. PubMed ID: 19167610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroesophageal junction and gastroesophageal junction carcinoma : a short update.
    Ekmektzoglou KA; Apostolopoulos P; Samelis G; Alexandrakis G
    Acta Gastroenterol Belg; 2016; 79(4):471-479. PubMed ID: 28209106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Dong H; Chen Y; Liu Q; Wu X; Zhou D; Tan D; Zhang H
    PLoS One; 2013; 8(11):e80665. PubMed ID: 24236193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
    Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
    JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
    Shan L; Ying J; Lu N
    Diagn Pathol; 2013 May; 8():76. PubMed ID: 23656792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.
    Neil AJ; Zhao L; Isidro RA; Srivastava A; Cleary JM; Dong F
    Mod Pathol; 2023 Jun; 36(6):100183. PubMed ID: 37054973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
    Bornschein J; Wernisch L; Secrier M; Miremadi A; Perner J; MacRae S; O'Donovan M; Newton R; Menon S; Bower L; Eldridge MD; Devonshire G; Cheah C; Turkington R; Hardwick RH; Selgrad M; Venerito M; Malfertheiner P; ; Fitzgerald RC
    Int J Cancer; 2019 Dec; 145(12):3389-3401. PubMed ID: 31050820
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
    Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
    Dragovich T; McCoy S; Fenoglio-Preiser CM; Wang J; Benedetti JK; Baker AF; Hackett CB; Urba SG; Zaner KS; Blanke CD; Abbruzzese JL
    J Clin Oncol; 2006 Oct; 24(30):4922-7. PubMed ID: 17050876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.
    Weinberg BA; Xiu J; Hwang JJ; Shields AF; Salem ME; Marshall JL
    Oncologist; 2018 Oct; 23(10):1171-1177. PubMed ID: 29703766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.
    Wood AC; Zhang Y; Mo Q; Cen L; Fontaine J; Hoffe SE; Frakes J; Dineen SP; Pimiento JM; Walko CM; Mehta R
    Oncologist; 2022 Apr; 27(4):307-313. PubMed ID: 35380714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
    Weigelt B; Bi R; Kumar R; Blecua P; Mandelker DL; Geyer FC; Pareja F; James PA; ; Couch FJ; Eccles DM; Blows F; Pharoah P; Li A; Selenica P; Lim RS; Jayakumaran G; Waddell N; Shen R; Norton L; Wen HY; Powell SN; Riaz N; Robson ME; Reis-Filho JS; Chenevix-Trench G
    J Natl Cancer Inst; 2018 Sep; 110(9):1030-1034. PubMed ID: 29506079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative histochemical evaluation of mucins expression in fetal esophagus and adenocarcinomas of the gastroesophageal junction.
    Vernygorodskyi S; Rekun T; Zhuchenko P
    Exp Oncol; 2018 Oct; 40(3):223-227. PubMed ID: 30285012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal
    Adeshuko FA; Squires MH; Poultsides G; Pawlik TM; Weber SM; Schmidt C; Votanopoulos K; Fields RC; Maithel SK; Cardona K
    Am Surg; 2017 Jan; 83(1):82-89. PubMed ID: 28234131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma.
    Waters R; Sewastjanow-Silva M; Yamashita K; Abdelhakeem A; Iwata KK; Moran D; Elsouda D; Guerrero A; Pizzi M; Vicentini ER; Shanbhag N; Ta A; Chatterjee D; Ajani JA
    JCO Precis Oncol; 2024 May; 8():e2300543. PubMed ID: 38781542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 Genetic Heterogeneity in Gastric Cancer: Evaluation According to the College of American Pathologists Breast Cancer Criteria.
    Treacy AD; Karamchandani JR; Streutker CJ; Grin A
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):628-32. PubMed ID: 25611242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.